Palbociclib plus letrozole as first-line therapy in estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer with extended follow-up
Document type:
Zeitschriftenaufsatz
Author(s):
Rugo, H. S.; Finn, R. S.; Diéras, V.; Ettl, J.; Lipatov, O.; Joy, A. A.; Harbeck, N.; Castrellon, A.; Iyer, S.; Lu, D. R.; Mori, A.; Gauthier, E. R.; Bartlett, C. Huang; Gelmon, K. A.; Slamon, D. J.